Oval Park Capital invests in early-stage companies in underserved markets in the United States. We support exceptional and diverse founders that have developed and are commercializing disruptive technologies to solve complex problems in large inefficient global industries. While Oval Park is generally industry-agnostic, most of our portfolio companies operate in large, inefficient, global industries where scientific and engineering breakthroughs can rapidly generate value. Some of these industries include healthcare, financial, cybersecurity, agricultural, sustainable food, animal health, clean energy, water, construction, and industrial technologies. Oval Park does not invest in human therapeutics, human medical devices, or any social or other media companies. Oval Park typically invests between $500,000 and $1,500,000 in Pre-Seed through Series A stage companies.